Barrington raised the firm’s price target on Merit Medical (MMSI) to $106 from $103 and keeps an Outperform rating on the shares after the company reported “strong” Q3 results and increased its FY25 guidance “materially.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical price target raised to $103 from $102 at Baird
- Merit Medical price target raised to $109 from $105 at Piper Sandler
- Cautious Hold Rating for Merit Medical Systems Amid Strong Q3 and Transitional Challenges
- Merit Medical Systems: Strong Financial Performance and Strategic Growth Drive Buy Rating
- Merit Medical Reports Strong Q3 2025 Growth